We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002714:SZSEMuyuan Foods Co., Ltd. Class A Analysis

Data as of 2026-08-29 - not real-time

CN¥41.68

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Muyuan Foods Group Co., Ltd. trades at ¥41.68, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 4.6% over the past 30 days. With RSI at 63.4 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at ¥37.63 and resistance at ¥41.85.
On valuation the read is undervalued — an earnings multiple of 12.7, absent a reliable peer benchmark. The average analyst target implies 25.7% above today's level. Revenue is contracting at 26.9% on a -0.9% profit margin. The 4.63% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 29.8%, a beta of 0.10 and a maximum drawdown of 44.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

HONG KONG, Feb 2, 2026 - ACN Newswire - On 29 January, Muyuan Foods Co.HONG KONG, Feb 6, 2026 - ACN Newswire - On 6 February, Muyuan Foods Co.Investing11monMuyuan Foodstuff Co LtdWe've identified the following companies as similar to Muyuan Foodstuff Co Ltd...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 43.64
  • MACD momentum is positive
  • Maximum drawdown of 44.9%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 43.64
  • Analyst targets imply +25.7% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -0.9%
  • Analyst targets imply +25.7% versus the current price
  • Negative return on equity of -1.3%

Key Metrics & Analysis

Financial Health

Revenue Growth-26.90%
Profit Margin-0.88%
P/E Ratio12.7
ROE-1.31%
ROA0.71%
Debt/Equity96.41
P/B Ratio3.0
Op. Cash FlowCN¥10.5B
Free Cash FlowCN¥2.5B

Technical Analysis

TrendNeutral
RSI63.4
SupportCN¥37.63
ResistanceCN¥41.85
MA 20CN¥39.50
MA 50CN¥38.37
MA 200CN¥43.64
MACDBullish
VolumeStable
Fear & Greed Index95.66

Valuation

Target PriceCN¥52.41
Upside/Downside25.74%
GradeUndervalued
TypeValue
Dividend Yield4.63%

Risk Assessment

Beta0.10
Volatility29.83%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.